One-step HCV RNA Testing Among SSP Participants (HOT Study)
Launched by UNIVERSITY OF WASHINGTON · Oct 7, 2024
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The HOT Study is looking into a new type of test for hepatitis C virus (HCV) that can give results quickly at syringe services programs (SSP), which help people who use drugs. The main goal is to see how this quick testing affects how people receive their results and whether it helps them get the care and treatment they need for HCV. The study will also explore the best ways to use this type of testing in these programs.
To be eligible for the study, participants need to be at least 22 years old and should not already know they have HCV or have participated in this study before. If you decide to join, you'll receive the quick test and, depending on the results, support to connect you to treatment if necessary. This study is not yet recruiting participants, but it's an important step in improving HCV testing and care for individuals who might be affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Minimum age of 22
- Exclusion Criteria:
- • Already knows they are infected with hepatitis C virus.
- • past participation in this study.
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Sara Glick, PhD, MPH
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported